Published date: 12 March 2019

Last edited date: 12 March 2019

This notice was replaced on 12 March 2019

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 25 March 2019, last edited 25 March 2019)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Blood coagulants - 33141530

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£192,000,000

Procurement reference

tender_192534/724684

Published date

12 March 2019

Closing date

11 December 2018

Contract start date

1 March 2019

Contract end date

28 February 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Invitation to offer for NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. Period of framework agreement: 1st March 2019 to 28th February 2021 with options to extend up to a further 24 months. Total maximum framework agreement including extension options will be no more than 48 months.

More information

Attachments

Links

About the buyer

Contact name

Philip Grieve

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

philip.grieve@nhs.net